UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5239) 5239
Newsletter (76) 76
Book Chapter (23) 23
Newspaper Article (18) 18
Dissertation (16) 16
Publication (7) 7
Conference Proceeding (6) 6
Magazine Article (6) 6
Web Resource (4) 4
Book / eBook (2) 2
Government Document (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3840) 3840
science & technology (3123) 3123
life sciences & biomedicine (2938) 2938
female (2246) 2246
mitoxantrone (2062) 2062
mitoxantrone - administration & dosage (1962) 1962
male (1923) 1923
middle aged (1828) 1828
adult (1586) 1586
antineoplastic combined chemotherapy protocols - therapeutic use (1499) 1499
oncology (1450) 1450
aged (1336) 1336
mitoxantrone - therapeutic use (941) 941
animals (803) 803
mitoxantrone - adverse effects (773) 773
mitoxantrone - pharmacology (735) 735
treatment outcome (697) 697
hematology (677) 677
antineoplastic combined chemotherapy protocols - adverse effects (635) 635
cytarabine - administration & dosage (635) 635
chemotherapy (592) 592
remission induction (520) 520
cancer (517) 517
pharmacology & pharmacy (515) 515
breast neoplasms - drug therapy (510) 510
antineoplastic agents - therapeutic use (492) 492
antineoplastic agents - pharmacology (475) 475
adolescent (454) 454
mitoxantrone hydrochloride (438) 438
etoposide - administration & dosage (424) 424
cyclophosphamide - administration & dosage (407) 407
multiple sclerosis (399) 399
antineoplastic combined chemotherapy protocols - administration & dosage (396) 396
mice (392) 392
drug administration schedule (357) 357
dose-response relationship, drug (350) 350
leukemia, myeloid, acute - drug therapy (349) 349
cell line, tumor (333) 333
antineoplastic agents - administration & dosage (330) 330
combined modality therapy (330) 330
aged, 80 and over (313) 313
prognosis (306) 306
survival analysis (304) 304
disease-free survival (300) 300
abridged index medicus (292) 292
survival rate (291) 291
research (285) 285
drug resistance, neoplasm (282) 282
breast cancer (279) 279
vincristine - administration & dosage (277) 277
multiple sclerosis - drug therapy (270) 270
drug resistance (267) 267
time factors (266) 266
neurosciences & neurology (264) 264
prednisone - administration & dosage (259) 259
mitoxantrone - pharmacokinetics (256) 256
doxorubicin - administration & dosage (253) 253
drug evaluation (249) 249
follow-up studies (245) 245
antineoplastic agents - adverse effects (241) 241
care and treatment (239) 239
recurrence (236) 236
drug therapy (235) 235
acute disease (233) 233
clinical neurology (233) 233
breast neoplasms - pathology (232) 232
lymphoma, non-hodgkin - drug therapy (219) 219
atp binding cassette transporter, sub-family g, member 2 (218) 218
biochemistry & molecular biology (218) 218
prostatic neoplasms - drug therapy (218) 218
cell survival - drug effects (217) 217
tumor cells, cultured (211) 211
retrospective studies (209) 209
mitoxantrone - chemistry (207) 207
mitoxantrone - metabolism (206) 206
medicine & public health (201) 201
prostate cancer (201) 201
chemistry (194) 194
daunorubicin - administration & dosage (194) 194
physical sciences (194) 194
analysis (193) 193
prospective studies (184) 184
methotrexate - administration & dosage (178) 178
mitoxantrone - toxicity (178) 178
antineoplastic agents (176) 176
atp-binding cassette transporters - metabolism (176) 176
doxorubicin - pharmacology (173) 173
health aspects (173) 173
clinical trials as topic (171) 171
leukemia, myeloid - drug therapy (169) 169
leukemia (167) 167
child (165) 165
anthraquinones - therapeutic use (163) 163
fluorouracil - administration & dosage (163) 163
multidrug resistance (162) 162
vidarabine - analogs & derivatives (160) 160
apoptosis (159) 159
doxorubicin (159) 159
cell line (158) 158
neoplasm proteins - metabolism (156) 156
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5025) 5025
Japanese (137) 137
German (122) 122
Chinese (76) 76
French (76) 76
Russian (33) 33
Spanish (30) 30
Italian (12) 12
Czech (10) 10
Polish (10) 10
Portuguese (8) 8
Hungarian (5) 5
Turkish (4) 4
Swedish (3) 3
Bulgarian (2) 2
Norwegian (2) 2
Ukrainian (2) 2
Dutch (1) 1
Korean (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of nanomedicine, ISSN 1176-9114, 2014, Volume 9, Issue 1, pp. 4055 - 4066
Tumor-targeting multifunctional liposomes simultaneously loaded with magnetic iron oxide nanoparticles (MIONs) as a magnetic resonance imaging (MRI) contrast... 
Magnetic resonance imaging | Mitoxantrone | Gonadorelin | Theranostic nanomedicine | Multifunctional liposome | Pharmacology & Pharmacy | Science & Technology - Other Topics | Nanoscience & Nanotechnology | Life Sciences & Biomedicine | Science & Technology | Humans | Contrast Media - pharmacokinetics | Gonadotropin-Releasing Hormone - pharmacology | Magnetic Resonance Imaging - methods | Gonadotropin-Releasing Hormone - pharmacokinetics | Gonadotropin-Releasing Hormone - chemistry | Mitoxantrone - chemistry | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Cell Survival - drug effects | Antineoplastic Agents - chemistry | Xenograft Model Antitumor Assays | Liposomes - chemistry | Magnetite Nanoparticles - chemistry | Animals | Mice, Nude | Cell Line, Tumor | Contrast Media - chemistry | Mice | Mice, Inbred BALB C | Mitoxantrone - pharmacology | Mitoxantrone - pharmacokinetics | Drug Delivery Systems - methods | Liposomes - pharmacokinetics | Complications and side effects | Usage | Ferric oxide | Mitoxantrone hydrochloride | Physiological aspects | Dosage and administration | Research | Liposomes | Methods | Nanoparticles | Contrast agents | Nuclear magnetic resonance--NMR | Peptides | Polyethylene glycol | Lipids | Systematic review | Cancer therapies | Ovarian cancer | Tumors | Index Medicus | mitoxantrone | multifunctional liposome | magnetic resonance imaging | gonadorelin | theranostic nanomedicine
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9747, pp. 1147 - 1154
Summary Background Cabazitaxel is a novel tubulin-binding taxane drug with antitumour activity in docetaxel-resistant cancers. We aimed to compare the efficacy... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prostatic Neoplasms - metabolism | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Prostatic Neoplasms - immunology | Antineoplastic Agents, Hormonal - therapeutic use | Treatment Failure | Neutropenia - chemically induced | Mitoxantrone - adverse effects | Prostatic Neoplasms - drug therapy | Taxoids - adverse effects | Prostatic Neoplasms - pathology | Prednisone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Administration, Oral | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Biomarkers, Tumor - blood | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Androgen Antagonists - therapeutic use | Aged | Infusions, Intravenous | Pain Measurement | Dosage and administration | Prednisone | Research | Drug therapy | Prostate cancer | Mitoxantrone hydrochloride | Studies | Chemotherapy | Medical imaging | Physicians | Family medical history | Radiation therapy | Clinical medicine | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 12/2011, Volume 82, Issue 12, pp. 1344 - 1350
Journal Article